After long haul, cancer bill passes
The Hill, December 26, 2012
A bipartisan cancer research bill—aimed at tackling the disease's most dangerous forms—has finally passed Congress after nearly six years of work. The Recalcitrant Cancer Research Act passed both chambers last week as part of the conference report on defense authorization bill. The bill will create scientific frameworks for addressing the most dangerous cancers.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- How Chargemaster Data May Affect Hospital Revenue
- Uncompensated Care Faces a Double Hit in Some States
- Hospital Pricing Transparency a Marketing Game Changer
- Primary Care Docs Average More Hospital Revenue Than Specialists
- ED Physicians Key to Half of Hospital Admissions
- Insurer's App Aims to Lower Healthcare Costs, Securely
